首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1666195

全球氣相層析系統市場 - 2025 - 2032

Global Gas Chromatography Systems Market - 2025-2032

出版日期: 2025年02月24日 | 出版商:

DataM Intelligence | 英文 205 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球氣相層析系統市場規模達到 36.6875 億美元，預計到 2032 年將達到 72.0359 億美元，在 2025-2032 年預測期內的複合年成長率為 8.8%。

推動這一成長的因素包括色譜技術的進步、各行業應用的增加以及政府對環境監測和食品安全的嚴格監管。氣相層析法 (GC) 在製藥業應用的最重要領域之一是藥物開發和品質控制程序。根據印度品牌資產基金會（IBEF）的數據，印度製藥業預計將發生轉型，到 2024 年規模約為 650 億美元，到 2030 年增至 1,300 億美元，然後到 2047 年迅速增至 4,500 億美元。

目前，印度製藥業價值估計為500億美元，光是出口就貢獻了250多億美元。這凸顯了在藥品製造過程中採用氣相層析法等先進技術的必要性，以遵守各種與健康相關的法規，因為它提供了擴展的空間。事實上，這些地區的環境和食品安全問題已經嚴重影響了北美和歐洲市場以及醫療和製藥領域開發和實施氣相層析法的努力。

此外，這些政府已經認知到採用這些方法解決食品安全和環境污染問題的必要性。例如，綜合加拿大的研究資助機構加拿大創新基金會 (CFI) 已投資約 900 萬美元用於開發必要的基礎設施，其中包括促進氣相層析質譜 (GC-MS) 研究。

動力學

醫療保健和製藥領域的重要應用

持續的技術進步和產業內策略合作的形成。 GC 系統的多樣化應用也是其成長的因素。這些應用涵蓋法醫科學、環境測試、製藥、化學品和食品安全。多樣化的可用性確保了現有和發展中經濟體市場需求的持續湧入。氣相層析市場具有良好的未來成長潛力，因為其特點是永續性和法規遵循性，以及新產品的推出。

預計預測期內醫藥最終用途的氣相層析系統將經歷大幅成長。 2023 年該領域的價值估計為 9.8247 億美元，預計 2024 年至 2031 年的年複合成長率(CAGR) 為 11.0%。該市場擴張的主要原因是在監管藥品註冊、品質控制和藥物開發過程中實施有效分析方法的必要性日益成長。

區域和全球合作不斷增多

世界各國政府已經認知到色譜技術在解決醫療保健、環境永續性和食品安全方面的挑戰的價值。加拿大政府投資了商業創新計劃，支持 Natrix Separations 等公司開發用於生物製藥製造的先進一次性色譜產品。

這些投資促進了尖端氣相層析技術的商業化，促進了精密儀器的發展和普及。同樣，歐盟透過「地平線歐洲」等項目積極資助合作研究項目，重點在於改進包括氣相層析系統在內的分析儀器，以滿足嚴格的環境和食品安全法規。

此外，公私合作夥伴關係在推進 GC 技術方面發揮關鍵作用。這種合作充分利用了私人公司和公共機構的資源和專業知識。例如，公私合作夥伴關係在推進 GC 技術方面發揮關鍵作用。這種合作充分利用了私人公司和公共機構的資源和專業知識。例如，美國環保署 (EPA) 與 GC 製造商密切合作，以增強用於空氣和水質監測的儀器。這種合作關係確保了法規合規性，同時促進了儀器設計的創新。

高度依賴專用載氣

氣相層析（GC）系統市場主要依賴專門的載氣，例如氦氣。由於氦氣具有質量分離能力和非反應性，因此在氣相層析操作中是必不可少的。然而，全球範圍內的氦「危機」導致其價格變得更加昂貴且取得更加困難。生物系統的利用受到氦氣成本和供應量的上升的影響。美國能源部 (DOE) 報告稱，GC 價格昂貴，無法用於醫療和研究應用。

此外，由於全球氦氣稀缺，因此必須使用氫氣或氮氣等被視為劣質的載氣。根據美國國家標準與技術研究所 (NIST) 的數據，氫氣成本較低；但它也更易燃，這會帶來風險。這些複雜情況增加了實驗室和產業的營運和維護成本，需要實施額外的安全措施和設施。

The growth is driven by advancements in chromatography technologies, increased applications across industries and strong governmental regulations for environmental monitoring and food safety. One of the most significant sectors for the application of gas chromatography (GC) in the pharmaceutical industry is drug development and quality control procedures. The pharmaceutical sector in India is expected to transform, with a size of approximately US$ 65 billion by 2024, increasing to US$ 130 billion by 2030 and then rapidly increasing to US$ 450 billion by 2047, according to the India Brand Equity Foundation (IBEF).

Currently, it is estimated that the Indian pharmaceutical industry is worth US$ 50 billion, with a contribution of over US$ 25 billion from exports alone. This underscores the necessity of employing sophisticated techniques, such as gas chromatography, to comply with a variety of health-related regulations during the drug manufacturing process, as it provides space for expansion. In reality, the environmental and food safety concerns in these regions have significantly impacted efforts to develop and implement gas chromatography in North America and European markets, in addition to the medical and pharmaceutical sectors.

Additionally, these governments have acknowledged the necessity of employing these methods to resolve concerns regarding food safety and environmental pollution. For example, the Canada Foundation for Innovation (CFI), the research funding body of Integrated Canada, has invested approximately $9 million in the development of the requisite infrastructure, which includes facilitating gas chromatography-mass spectrometry (GC-MS) research.

Dynamics

Significant Applications in Healthcare and Pharmaceutical Sector

Ongoing technological advancements and the formation of strategic collaborations within the industry. The diverse applications of GC systems are also a contributing factor to their growth. These applications encompass forensic sciences, environmental testing, pharmaceuticals, chemicals and food safety. The continuous influx of demand for the existing and developing economies markets is ensured by the diverse usability. The gas chromatography market is well-positioned for future growth, as it is characterized by sustainability and regulatory compliance, in addition to the introduction of new products.

It is anticipated that the gas chromatography system in pharmaceutical end-use will experience substantial growth during the forecast period. This segment was estimated to be worth US$ 982.47 Million in 2023 and is anticipated to experience a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031. The primary reason for the expansion of this market is the growing necessity for the implementation of effective analytical methods in the processes of regulatory drug registration, quality control and drug development.

Rising Regional and Global Collaborations

Governments worldwide have recognized the value of chromatography technologies in addressing challenges in healthcare, environmental sustainability and food safety. The Canadian government has invested in the Business Innovation Initiative, which supports companies like Natrix Separations in developing advanced single-use chromatography products for biopharmaceutical manufacturing.

The investments promote the commercialization of cutting-edge GC technologies, facilitating the development of precision instruments and increasing adoption. Similarly, The European Union actively funds collaborative research projects through programs like Horizon Europe, focusing on improving analytical instruments, including GC systems, to meet stringent environmental and food safety regulations.

Furthermore, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, The Environmental Protection Agency (EPA) works closely with GC manufacturers to enhance instruments used in air and water quality monitoring. This partnership ensures regulatory compliance while fostering innovation in instrument design.

High Dependency on Specialized Carrier Gases

The market for gas chromatography (GC) systems is primarily dependent on specialized carrier gases, such as helium. Helium is essentially indispensable in the operation of GCs due to its capacity for quality separation and non-reactivity. However, there is a global helium "crisis" that renders it significantly more expensive and difficult to obtain. The utilization of a biosystem was influenced by the rise in the cost and supply of helium. The US Department of Energy (DOE) has reported that GC has been rendered expensive and inaccessible for use in both medical and research applications.

Additionally, the global scarcity of helium necessitates the use of carrier gases, such as hydrogen or nitrogen, which are regarded as inferior. According to the National Institute of Standards and Technology (NIST), hydrogen is less expensive; however, it is also more flammable, which poses a risk. These complications increase the costs of operations and maintenance for laboratories and industries, necessitating the implementation of additional safety measures and facilities.

Segment Analysis

The global gas chromatography systems market is segmented based on product type, sample type, end-user and region.

Adoption of Advanced Detectors Fuels the Demand of Gas Chromatography Systems Instruments

The instruments segment is poised for steady growth, driven by technological advancements, regulatory requirements and increasing demand across sectors including pharmaceuticals, food safety and environmental monitoring. Key factors include the adoption of advanced detectors, integration with automation software and the miniaturization of portable units.

For instance, in May 2024, Agilent Technologies launched the 8850 Gas Chromatograph (GC) System, a compact single-channel GC that blends the legacy of the 6850 GC with the advanced capabilities of the 8890 GC. Designed for efficiency and intelligence, the 8850 GC is tailored to meet the needs of modern labs in energy, chemicals, food and pharmaceuticals, offering up to 30% reduced energy consumption. It addresses key challenges such as maximizing productivity within limited bench space and aligning operations with sustainability goals by enhancing instrument uptime and operational efficiency.

Geographical Penetration

Rising Demand for Accurate Chemical Analysis in North America

North America gas chromatography market is witnessing consistent expansion, primarily fueled by innovations in analytical methodologies and a rising demand for accurate chemical analysis across various sectors. Critical areas including medicines, environmental monitoring, food and drinks and chemicals are driving the increasing demand for gas chromatography equipment. Technological developments, including miniaturization, automation and the integration of artificial intelligence (AI) for data processing, are boosting the capabilities and efficiency of gas chromatography systems, further expanding their market presence.

Gas chromatography has found significant application in the oil and gas industry, where it plays a key role in assuring the quality and uniformity of chemical analysis. In recent years, North America's total crude oil output attained 46,233,753 Terajoules (TJ), reflecting a 66% increase from 2000, as reported by the International Energy Agency (IEA). The rise of the oil and gas sector is directly fostering the growth of the gas chromatography market, as these systems are essential for analyzing the composition of hydrocarbons and other gases.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bruker Corporation, PerkinElmer, Inc., Merck KGAA, Shimadzu Corporation, Waters Corporation, Emerson Electric Co., SCION Instruments and Danaher Corporation.

Sustainable Analysis

Gas chromatography plays a crucial role in environmental sustainability by ensuring the precise identification and quantification of contaminants. Its accuracy and versatility render it essential for assessing ecological well-being and adhering to changing requirements These cutting-edge instruments address evolving industry needs across pharmaceuticals, food safety and environmental monitoring. With a focus on productivity and sustainability, the market is poised for sustained growth across diverse applications.

The demand for gas chromatography is especially prominent in areas prioritizing healthcare improvements. The National Cancer Center of Japan estimated more than 1 million new cancer cases in 2022, highlighting the increasing demand for accurate analytical methods in oncology research. In Saudi Arabia, the Vision 2030 project has catalyzed investments in healthcare, biotechnology and environmental sustainability.

Recent Developments

In October 2024, Bruker BioSpin Group has announced the acquisition of Bridge12's Electron Paramagnetic Resonance (EPR) business. This acquisition enhances Bruker's suite of EPR spectroscopy offerings, including Bridge12's modular EPR bridges for pulsed spectroscopy, high-field EPR spectrometers for multi-frequency experiments, microwave amplifiers and EPR probes. The addition of Bridge12's innovative technology, including its compact Q-Band EPR resonator for small sample analysis, strengthens Bruker's position in the research industry.
In June 2024, Agilent Technologies Inc. has introduced the Agilent 7010D Triple Quadrupole GC/MS System (7010D GC/TQ). To target the food and environmental markets, the 7010D GC/TQ features the new HES 2.0 ion source, offering attogram-level sensitivity, advanced built-in intelligence and environmentally conscious design with the My Green Lab ACT Label. Paired with the MassHunter Acquisition 13.0 software, the system enhances data integrity and compliance, reflecting Agilent's commitment to precision and sustainability.
In December 2023, PerkinElmer Inc. has announced its acquisition of Covaris, to create an innovation-driven global life sciences and diagnostics platform. This strategic move will accelerate Covaris' growth potential and broaden PerkinElmer's portfolio, particularly in the rapidly expanding diagnostics market. The merger strengthens PerkinElmer's position in genomics, transcriptomics and proteomics, offering significant growth opportunities in diagnostics, biopharma and clinical research globally.

By Product Type

Instrument
- Gas Chromatography-Mass Spectrometry (GC-MS)
- Gas Chromatography-Flame Ionization Detection (GC-FID)
- Gas Chromatography-Electron Capture Detection (GC-ECD)
- Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
- Others
Accessories & Reagents

By Sample Type

Gas-Liquid Chromatography (GLC)
Gas-Solid Chromatography (GSC)

By End-User

Pharmaceutical Companies
Biotechnology Companies
Forensic Departments
Academic and Research Institutes
F&B Industries
Oil & Gas Industries
Environmental Testing Agencies
Others

By Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Why Purchase the Report?

To visualize the global gas chromatography systems market segmentation based on product type, sample type, end-user, & region.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points at the gas chromatography systems market level for all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global gas chromatography systems market report would provide approximately 62 tables, 55 figures and 205 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Sample Type
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Significant Applications in Healthcare and Pharmaceutical Sector
  - 4.1.1.2. Rising Regional and Global Collaborations
- 4.1.2. Restraints
  - 4.1.2.1. High Dependency on Specialized Carrier Gases
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainable Analysis
5.6. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Instruments*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.2.2.1. Gas Chromatography-Mass Spectrometry (GC-MS)
  - 6.2.2.2. Gas Chromatography-Flame Ionization Detection (GC-FID)
  - 6.2.2.3. Gas Chromatography-Electron Capture Detection (GC-ECD)
  - 6.2.2.4. Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
  - 6.2.2.5. Others
6.3. Accessories & Reagents

7. By Sample Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 7.1.2. Market Attractiveness Index, By Sample Type
7.2. Gas-Liquid Chromatography (GLC)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gas-Solid Chromatography (GSC)

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical Companies*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Biotechnology Companies
8.4. Forensic Departments
8.5. Academic and Research Institutes
8.6. F&B Industries
8.7. Oil & Gas Industries
8.8. Environmental Testing Agencies
8.9. Others

9. Sustainability Analysis

9.1. Environmental Analysis
9.2. Economic Analysis
9.3. Governance Analysis

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. US
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Key Region-Specific Dynamics
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Agilent Technologies Inc.
12.3. Bruker Corporation
12.4. PerkinElmer, Inc.
12.5. Merck KGAA
12.6. Shimadzu Corporation
12.7. Waters Corporation
12.8. Emerson Electric Co.
12.9. SCION Instruments
12.10. Danaher Corporation

LIST NOT EXHAUSTIVE